Medical Advisory Board | Clinical

Betsy C. Herold, MD, FPIDS

Chief, Division of Pediatric Infectious Disease
Harold and Muriel Block Chair in Pediatrics
Vice Chair, Research
Director, Translational Prevention Research Center
Children's Hospital at Montefiore Professor of Pediatrics
Albert Einstein College of Medicine

A renowned physician, scientist, and academic leader, Dr. Betsy Herold is a pediatric infectious disease specialist in New York. In addition to her clinical research focusing on the prevention of HIV and HSV and other sexually transmitted infections, Dr. Herold's interests include prevention of infectious disease complications in transplantation, including studies to optimize pre-emptive prophylaxis for CMV and EBV, vaccine responses in transplantation recipients, and other related infectious complications. Dr. Herold also serves as vice chair for research development in the Department of Pediatrics at CHAM and Einstein. She is a professor of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women’s Health, and holds the Harold and Muriel Block Chair of Pediatrics at Einstein. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania.

Michele I. Morris, MD, FIDSA, FAST

Director Immunocompromised Host Section
Division of Infectious Diseases

Medical Director Infection Control & Antimicrobial Stewardship
Sylvester Cancer Center

Director Transplant Infectious Diseases Fellowship

Professor of Clinical Medicine Division of Infectious Diseases

Dr. Michele Morris is an infectious disease specialist in Miami, Florida and is affiliated with Jackson Memorial Hospital, University of Miami Hospital and Clinics and University of Miami Sylvester Comprehensive Cancer Center. Clinical areas of focus include infections in immunocompromised patients including solid organ and stem cell transplant recipients, hematology/oncology patients, primary immunodeficiency patients, and patients treated with immunosuppressive agents for rheumatologic, gastrointestinal, or dermatologic conditions, invasive fungal infections, tropical infectious diseases in immunocompromised patients, pre-transplant evaluation and clearance, HIV management in transplant candidates or recipients, and patients receiving cancer treatment. Dr. Morris received her medical degree from Perelman School of Medicine at the Medical College of Pennsylvania and has been in practice more than 20 years.

Luis Ostrosky-Zeichner, MD, FACP, FIDSA

Professor and Memorial Hermann Endowed Chair
Chief, Division of Infectious Diseases
Vice Chair for Healthcare Quality
University of Texas Health Science Center at Houston

Dr. Luis Ostrosky-Zeichner is a distinguished professor of medicine and epidemiology at McGovern Medical School, UTHealth, where he holds the Memorial Hermann Endowed Chair and leads the Division of Infectious Diseases. He is also the Vice-Chair of Medicine for Healthcare Quality, Director of the Laboratory of Mycology Research, and Chief Epidemiology Officer for Memorial Hermann Healthcare System and UT Physicians. Dr. Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autónoma de México and completed his residency and fellowship at notable institutions including MD Anderson Cancer Center. He is a fellow of multiple prestigious societies and serves as Senior Editor for the Journal of Antimicrobial Chemotherapy. His expertise spans medical mycology, healthcare epidemiology, and antimicrobial stewardship, with over 200 published peer-reviewed articles.

Dr. Kapil K. Saharia, MD, MPH

Associate Professor
Chief, Solid Organ Transplant Infectious Diseases Service
University of Maryland School of Medicine
Assistant Professor of Medicine
Institute of Human Virology

Dr. Kapil Saharia earned his medical degree from Duke University and completed his Internal Medicine-Pediatrics residency at Yale-New Haven Hospital, where he was Chief Resident. He then pursued an Infectious Diseases Fellowship at the University of Maryland Medical Center and conducted post-doctoral research at the NIH Vaccine Research Center, focusing on Mycobacterium tuberculosis-specific CD4 T cells. Since 2012, Dr. Saharia has been an Assistant Professor at the Institute of Human Virology, where he serves as Chief of the Transplant Infectious Disease section. His clinical practice addresses infections in transplant recipients, patients with mechanical cardiac devices, and HIV-infected individuals. His research includes infectious outcomes in transplants and mycobacterial infections, with involvement in NIH and industry-sponsored trials.

Dr. Fernanda P. Silveira, MD, MS, FIDSA, FAST

Professor of Medicine
Director of Clinical Operations
Transplant Infectious Diseases
University of Pittsburgh School of Medicine and UPMC

Dr. Fernanda Silveira has worked as a Transplant Infectious Diseases physician and clinical researcher for over 15 years. She is a Professor of Medicine at the University of Pittsburgh and the director of clinical operations for Transplant Infectious Diseases at the University of Pittsburgh Medical Center (UPMC). She obtained her medical degree at the Federal University of Rio de Janeiro, in Brazil. She then completed her Internal Medicine Residency at the University of Miami, followed by Infectious Diseases and Transplant Infectious Diseases Fellowships at the University of Pittsburgh Medical Center (UPMC).
Dr. Silveira’s clinical and research interests are in infections in organ transplant recipients, particularly CMV, respiratory virus infections, and fungal infections.